SUMMARY The levels of A, H, I, and i plasma antigens and of anti-B, anti-I, and anti-T antibodies were measured in 70 subjects with colonic or gastric carcinoma. These studies showed a significant increase in A plasma activity of the A subjects, and in H plasma activity of the 0 subjects, while 25 % of the tested subjects showed increased I plasma activity. There was no difference in i plasma activity between cancer patients and healthy subjects. These results take into account the marked polymorphism acquired by neoplastic tissue, which is capable also of producing a greater quantity of antigens than that of healthy subjects. Nevertheless this heterogeneity forms a barrier to the clinical measurement of these plasma antigens for screening neoplasms. The significant fall in the amount of anti-T antibodies seemed to be secondary to the absorption of these antibodies on the surface of the tumour cells.
gastrointestinal tract, whereas the I substance seemed to be present in an abnormally high quantity (Feizi, 1978) . (I antigen could be a precursor of the biosynthesis of H antigen.) Stellner et al. (1973) showed, in adenocarcinoma cells, the disappearance of enzyme activities capable of transforming Hi glycolipids into A or B glycolipids.
The present study was undertaken to find out if the modifications seen in tumour tissue from the gastrointestinal tract had any effect on the level of A, H, I, and i substances and anti-B, anti-I, and anti-T antibodies in the serum in order to investigate the potential value of their use in cancer screening.
Material and methods
The titration of A, H, I, and i plasma antigens is based on the inhibition of haemagglutination. The Received for publication 6 March 1979 basic agglutination must be as weak as possible, but at the same time detectable in the used system. The agglutination obtained with a low-antibody concentration can thus be inhibited by a low-substance concentration.
Increasing dilutions of plasma were mixed for 2 hours at 20'C with a constant antibody concentration (inhibition phase). After fixation the amount of free antibodies was measured by their ability to agglutinate specific red cells. The agglutination phase of non-treated red cells was performed in a manifold combined with an autoanalyser (Rouger et al., unpublished observation (Fig.1) .
Plasma dilutions mixed with antibodies were pumped and flowed in a reaction coil. A red blood cell solution and PVP were added. This mixture reacted for 30 minutes. The reaction coil was at 100C or 15'C, according to the system used (Table 1) Thus 70 subjects with gastric or colonic cancers without metastasis were tested. The diagnosis was confirmed by histological examination after surgery. Each pathological population was compared with a healthy population (180 subjects). Both the healthy and cancer populations were identical as far as age and sex were concerned (patients were aged between 25 and 65; 50% were men and 50% were women). than that in healthy group 0 subjects (P 0 01). On the other hand, H plasma activity in A1 subjects was identical in the two populations. In the healthy subjects, A and H activities were dependent on Lewis and secretor phenotypes, while the abnormal A and H activities in cancer subjects were independent of these systems (Table 2) . (Fig. 2) . On the other hand, i activity was identical in the two populations (Fig. 3) . The I and i plasma activities were independent of the Lewis and secretor phenotypes in both the healthy and cancer subjects.
The levels of anti-B and anti-I were identical in both the healthy and cancer populations, while the level of anti-T antibodies was significantly lower in the patients with gastric and colonic cancers (P 0-02) . No difference could be detected in the levels of these antibodies between subjects with gastric and colonic carcinomas (Table 3) .
Discussion
The methodological problems posed by the detection and dosage of A, H, I, and i plasma activities have already been discussed (Rouger et al., unpublished observations).
If numerous tissues are capable of producing A and H antigens, especially in gastric and colonic tissues (Szulman, 1962) , the cells producing the A, H, I, and i plasma substances have still not been identified, perhaps due to the large number of cell types involved. Even if the tumour cells are directly responsible for the synthesis of an excess of A and H substances, the consequence at the plasma level could be moderated more often due to the vascular space, which is an important dilution factor. Nevertheless the increased A, H, and I plasma antigens in certain cancer subjects could be due to the neoplastic cells overproducing A, H, and I substances, the biochemical support of which has not yet been precisely defined.
Some authors (Barber and Dunsford, 1959; Salmon and Malassenet, 1960; Saeed and Fine, 1968) (Anglin et al., 1977) , originating from a breast cancer, glycoproteins with blood group activity were present in the culture medium. In the HeLA line, cells in culture possess H specificity (carried by the glycoproteins, notably CEA) and can be converted in vitro in A or B specificity (Pann and Kuhns, 1972; Mousseron-Canet et al., 1975; Bali et al., 1976) . These results take into account the persisting activity of the synthesis of blood group substances of the tumour cells on the one hand and the marked polymorphism of the different cells on the other.
Elsewhere, many authors (Nairn et al., 1962; Davidsohn et al., 1971; Lill et al., 1976; Lin et al., 1977) 
